This inventor holds 1 USPTO granted patent. Top assignee: Centro De Inmunologia Molecular. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: The Innovative Contributions of Angel Mauro Fernandez
Introduction
Angel Mauro Fernandez is a notable inventor based in Habana, Cuba. He has made significant contributions to the field of immunotherapy, particularly in the treatment of malignancies. His work focuses on the development of innovative strategies that target specific cellular components involved in cancer.
Latest Patents
Fernandez holds a patent for "Anti ganglioside monoclonal antibodies." This invention relates to immunotherapy strategies aimed at treating malignancies by targeting gangliosides. Gangliosides are glycosphingolipids found on both normal and malignant cells, with a higher abundance and distinct organization on cancerous cells. The patent provides antibodies that specifically recognize these gangliosides, which are valuable as immunoregulators. Additionally, the invention includes anti-idiotypic antibodies against anti-ganglioside antibodies, which can be utilized in vaccination strategies. He has 1 patent to his name.
Career Highlights
Fernandez is associated with the Centro de Inmunología Molecular, where he has been instrumental in advancing research in immunotherapy. His innovative approaches have the potential to improve treatment outcomes for patients suffering from various malignancies.
Collaborations
Some of his notable coworkers include Ana Maria Lopez and Rolando Perez Rodriguez. Their collaborative efforts contribute to the ongoing research and development in the field of immunology.
Conclusion
Angel Mauro Fernandez's work in the field of immunotherapy exemplifies the impact of innovative thinking in medical science. His contributions are paving the way for new treatment strategies that could significantly benefit cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile